Palisade Bio (PALI) Current Assets (2010 - 2026)
Palisade Bio (PALI) reported Current Assets of $133.2 million for Q1 2026, up 1589.4% year-over-year from $7.9 million in Q1 2025, and down 0.73% on a QoQ basis from $134.2 million in Q4 2025.
Palisade Bio (PALI) has 17 years of Current Assets data on file, last reported at $133.2 million in Q1 2026.
- Quarterly Current Assets rose 1589.4% year-over-year to $133.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.2 million (up 1589.4% YoY) and the FY2025 annual result came in at $134.2 million, up 1179.03% from the prior year.
- Current Assets eased to $133.2 million in Q1 2026 per PALI's latest filing, from $134.2 million in the prior quarter.
- Across five years, Current Assets topped out at $134.2 million in Q4 2025 and bottomed at $6.4 million in Q2 2025.
- The 5-year median for Current Assets is $12.3 million (2024), against an average of $25.8 million.
- The widest annual swing landed in 2022, when Current Assets slumped 49.64%; it then surged 1589.4% in 2026.
- Tracing PALI's Current Assets over 5 years: stood at $14.7 million in 2022, then decreased by 9.54% to $13.3 million in 2023, then dropped by 21.26% to $10.5 million in 2024, then jumped by 1179.03% to $134.2 million in 2025, then slipped by 0.73% to $133.2 million in 2026.
- Per Business Quant, the three latest PALI Current Assets figures stand at $133.2 million (Q1 2026), $134.2 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 133.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133.24 Mn |
| Dec 31, 2025 | 134.22 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 6.45 Mn |
| Mar 31, 2025 | 7.89 Mn |
| Dec 31, 2024 | 10.49 Mn |
| Sep 30, 2024 | 8.87 Mn |
| Jun 30, 2024 | 12.31 Mn |
| Mar 31, 2024 | 12.01 Mn |
| Dec 31, 2023 | 13.33 Mn |
| Sep 30, 2023 | 16.27 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Mar 31, 2023 | 14.31 Mn |
| Dec 31, 2022 | 14.73 Mn |
| Sep 30, 2022 | 15.16 Mn |
| Jun 30, 2022 | 7.42 Mn |
| Mar 31, 2022 | 8.26 Mn |
| Dec 31, 2021 | 11.51 Mn |
| Sep 30, 2021 | 16.09 Mn |
| Jun 30, 2021 | 14.73 Mn |
| Mar 31, 2021 | 8.76 Mn |
| Dec 31, 2020 | 896,000.00 |
| Sep 30, 2020 | 14.99 Mn |
| Jun 30, 2020 | 16.24 Mn |
| Mar 31, 2020 | 10.46 Mn |
| Dec 31, 2019 | 5.65 Mn |
| Sep 30, 2019 | 7.97 Mn |
| Jun 30, 2019 | 2.71 Mn |
| Mar 31, 2019 | 4.54 Mn |
| Dec 31, 2018 | 6.51 Mn |
| Sep 30, 2018 | 6.51 Mn |
| Jun 30, 2018 | 7.91 Mn |
| Mar 31, 2018 | 10.21 Mn |
| Dec 31, 2017 | 12.45 Mn |
| Sep 30, 2017 | 14.71 Mn |
| Jun 30, 2017 | 11.69 Mn |
| Mar 31, 2017 | 17.17 Mn |
| Dec 31, 2016 | 20.90 Mn |
| Sep 30, 2016 | 6.69 Mn |
| Jun 30, 2016 | 11.84 Mn |
| Mar 31, 2016 | 8.74 Mn |
| Dec 31, 2015 | 13.43 Mn |
| Sep 30, 2015 | 19.56 Mn |
| Jun 30, 2015 | 24.73 Mn |
| Mar 31, 2015 | 29.15 Mn |
| Dec 31, 2014 | 28.16 Mn |
| Sep 30, 2014 | 27.73 Mn |
| Jun 30, 2014 | 30.84 Mn |
| Mar 31, 2014 | 34.11 Mn |
| Dec 31, 2013 | 17.62 Mn |
| Sep 30, 2013 | 17.33 Mn |
| Jun 30, 2013 | 11.97 Mn |
| Mar 31, 2013 | 13.54 Mn |
| Dec 31, 2012 | 7.65 Mn |
| Sep 30, 2012 | 10.16 Mn |
| Jun 30, 2012 | 2.83 Mn |
| Mar 31, 2012 | 5.78 Mn |
| Dec 31, 2011 | 3.02 Mn |
| Sep 30, 2011 | 4.85 Mn |
| Jun 30, 2011 | 6.45 Mn |
| Dec 31, 2010 | 9.83 Mn |